CNE000001501
CNE000001501
HENAN LINGRUI PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 11.15B EUR | 10.99B EUR | 12.68B EUR | 11.74B EUR |
Enterprise Value | 10.04B EUR | 10.61B EUR | 12.5B EUR | 11.76B EUR |
Valuation Multiples | ||||
Trailing P/E | 13.85x | 18.21x | 20.69x | 20.15x |
Forward P/E | 13.11x | -- | -- | -- |
Price to Sales | 2.86x | 3.71x | 4.2x | 4.03x |
Price to Book | 3.45x | 3.4x | 3.47x | 3.45x |
EV/Revenue | 2.57x | 3.59x | 4.14x | 4.04x |
EV/EBITDA | 10.58x | 14.89x | 17.41x | 17.26x |
Price to FCF (P/FCF) | 16.62x | 14.78x | 24.5x | 31.93x |
EV/FCF | 14.97x | 14.27x | 24.17x | 31.97x |
FCF Yield | 6.02% | 6.77% | 4.08% | 3.13% |